This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fayad, M. Articles by Mikati, M. Search for Related Content PubMed PubMed Citation Articles by Fayad, M. Articles by Mikati, M. Social Bookmarking                   What's this?

Fatality From Hepatitis A in a Child Taking Valproate

Department of Pediatrics and Epilepsy Program American University of Beirut Medical Center Beirut, Lebanon, mrfayad{at}dm.net.lb

Roula Choueiri, MD

Department of Pediatrics and Epilepsy Program American University of Beirut Medical Center Beirut, Lebanon

Mohamad Mikati, MD

Department of Pediatrics and Epilepsy Program American University of Beirut Medical Center Beirut, Lebanon

We report an 8-year-old boy with complex partial seizures due to congenital stroke, treated with valproate for more than 3 years (the last 2 years were on monotherapy) with no complications during that period except for transient thrombocytopenia. His sister had uncomplicated hepatitis A. One month later, the patient became jaundiced, went into fulminant hepatic failure, and quickly became encephalopathic despite discontinuation of valproate, aggressive supportive therapy, and treatment with carnitine. He then died. He had positive hepatitis A IgM; other causes for acute hepatitis were ruled out. Liver pathology revealed distended hepatocytes with cholestasis and microvesicular changes. We could find in the literature two other articles on four cases who developed liver failure with hepatitis A while on valproate. All those cases, however, recovered. In our patient a usually benign disease became deadly, probably because of the concomitant use of a hepatotoxic medication. Immunizing, with hepatitis A vaccine, all children on valproate therapy who are living in, or traveling to, endemic areas should be considered and is probably advisable. (J Child Neurol 2000;15:135-136).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?